Proteomic profiling in breast cancers has identified PHGDH as one of the proteins expressed specifically in triple-negative breast cancers, which often have a basal-like phenotype defined by positivity for EGFR and CK5 [20,27]. This evidence concerns the gene EGFR and breast cancer.